Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
The first Yaz of case set to go to trial on January 9th has taken an interesting turn. The federal judge overseeing thousands of Yaz, Yasmin and Ocella venous thromboembolism lawsuits has ordered that all parties instead meet with a special mediator in order to negotiate a settlement for the litigation. The December 31st order [...]
The FDA is taking time to warn pharmacists about potential dispensing errors that could occur as a result of a mix-up between 2 drugs with very similar brand names. Confusion over the two medications could cause patients to be given the wrong prescription and subsequently endure serious injuries. The two brands in question are Durezol [...]
Japanese drug maker, Daiichi Sankyo, announced that its Indian unit, pharmaceutical giant, Ranbaxy Laboratories, Ltd., had reached an agreement with the U.S. Food and Drug Administration regarding its manufacturing practices. The company’s settlement with the FDA outlines its intent to improve procedures and policies in its production facilities in order to ensure data integrity and [...]
The U.S. Food and Drug Administration has ordered drug maker, Sanofi-Aventis, to update the label for its anti-arrhythmic medication, Multaq, in order to inform users of the increased risk for death or serious cardiovascular events when taken by patients with permanent atrial fibrillation. The FDA has approved Multaq (dronedarone) to treat atrial flutter and paroxysmal [...]
The U.S. Justice Department announced this week that drug maker, Merck, will pay a staggering $950 million to resolve investigations into the illegal marketing practices of its popular painkiller, Vioxx. Specifically, Merck will pay $321.6 million in criminal fines and $628.4 million as part of the civil settlement. The company will also plead guilty to [...]
In an online news article posted to Bloomberg’s website this week, it seems that pharmaceutical giant, Bayer AG, could have misled women regarding the potential health risks associated with use of their newer generation of birth control pills. According to information collected from the review of internal company e-mails, Bayer may have even sought to [...]
The fate of Bayer’s highly-controversial birth control pill, Yaz, is in the hands of the U.S. Food and Drug Administration. The regulatory agency will meet on December 8th in order to determine whether or not the drug should be allowed to stay on the market. Following the analysis of data collected from an agency-funded study [...]
In the wake of GlaxoSmithKline’s announcement that the London-based company will pay the U.S. government $3 billion to settle civil and criminal charges over the illegal marketing of Avandia, U.S. District Judge Cynthia Rufe is now pushing for the resolution of all remaining patient lawsuits over the medication. To that end, Judge Rufe this week [...]
One of the largest manufacturers of generic drugs, Teva Pharmaceuticals, was recently accused of placing profit ahead of the safety of colonoscopy patients using their anesthetic, Propofol. Teva, along with its distrutors, Baxter International and McKesson Corporation, are being sued for marketing and selling Propofol in jumbo-sized vials, knowing that doctors would possibly reuse the [...]
In a new drug safety communication posted today on the U.S. Food and Drug Administration’s website, the agency announced that preliminary results of a study involving 800,000 women suggest a 1.5-fold increase in the risk of blood clots for those women using drospirenone-containing birth-control pills, compared to those taking other forms of hormonal contraceptives. Popular [...]
